IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.13% | 25.17% | 10.44% | 17.81% | 13.31% |
| Total Depreciation and Amortization | 134.54% | 95.03% | 94.18% | 4.22% | -14.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.33% | 606.28% | 8.02% | 134.36% | -41.63% |
| Change in Net Operating Assets | 194.84% | -1,952.46% | -92.87% | -40.29% | 26.38% |
| Cash from Operations | 93.15% | -1.07% | -23.36% | 16.69% | 10.53% |
| Capital Expenditure | 89.10% | 89.46% | 70.14% | -132.36% | -1,266.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.00% | 54.20% | 37.52% | -38.75% | -5.67% |
| Cash from Investing | 88.03% | 86.38% | 68.50% | -122.37% | -718.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 56.90% | -327.66% | -66.29% | -50.23% | -81.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.22% | -350.01% | -13.79% | -13.79% | 72.89% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.40% | -349.78% | -14.28% | -15.17% | 71.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 374.04% | -1,146.03% | 10.81% | -21.82% | 58.95% |